Obesity and cancer risk: evidence, mechanisms, and recommendations
Top Cited Papers
Open Access
- 10 October 2012
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1271 (1), 37-43
- https://doi.org/10.1111/j.1749-6632.2012.06750.x
Abstract
Obesity, a growing health problem worldwide, has been associated with the metabolic syndrome, diabetes, cardiovascular disease, hypertension, and other chronic diseases. Recently, the obesity–cancer link has received much attention. Epidemiological studies have shown that obesity is also associated with increased risk of several cancer types, including colon, breast, endometrium, liver, kidney, esophagus, gastric, pancreatic, gallbladder, and leukemia, and can also lead to poorer treatment and increased cancer-related mortality. Biological mechanisms underlying the relationship between obesity and cancer are not well understood. They include modulation of energy balance and calorie restriction, growth factors, multiple signaling pathways, and inflammatory processes. Key among the signaling pathways linking obesity and cancer is the PI3K/Akt/mTOR cascade, which is a target of many of the obesity-associated factors and regulates cell proliferation and survival. Understanding the molecular and cellular mechanisms of the obesity–cancer connection is important in developing potential therapeutics. The link between obesity and cancer underscores the recommendation to maintain a healthy body weight throughout life as one of the most important ways to protect against cancer.Keywords
This publication has 58 references indexed in Scilit:
- Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2Proceedings of the National Academy of Sciences of the United States of America, 2011
- Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight GainCell, 2010
- Body-Mass Index and Mortality among 1.46 Million White AdultsThe New England Journal of Medicine, 2010
- Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in miceMolecular Carcinogenesis, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinomaOncogene, 2009
- Tumours with PI3K activation are resistant to dietary restrictionNature, 2009
- IP6K2 is a client for HSP90 and a target for cancer therapeutics developmentProceedings of the National Academy of Sciences of the United States of America, 2008
- HSP90 regulates cell survival via inositol hexakisphosphate kinase-2Proceedings of the National Academy of Sciences of the United States of America, 2008
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004